MedPath

Normal Range of TSH and FT4 in Pregnancy

Completed
Conditions
Hypothyroidism
Pregnancy Related
Thyroid
Dysfunction
Iodine Deficiency
Interventions
Diagnostic Test: Serum thyroid function tests
Registration Number
NCT04860622
Lead Sponsor
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Brief Summary

Physiological changes necessitate the use of pregnancy-specific reference ranges for thyrotrophin (TSH) and free T4 (FT4) to diagnose thyroid dysfunction during pregnancy. Although many centers use fixed upper limits for TSH of 2.5 or 3.0 mU/L, this may lead to overdiagnosis or even overtreatment.

The new guidelines of the American Thyroid Association have considerably changed recommendations regarding thyroid function reference ranges in pregnancy accordingly. Any hospital or physician that is still using the 2.5 or 3.0 mU/l cut-off for TSH during pregnancy should evaluate their own lab-specific cut-offs.

The investigator's objective is to establish a rational reference range of serum TSH for the diagnosis of subclinical hypothyroidism in the first, second, and third trimester of pregnant women in the Sancaktepe region in Turkey.

Detailed Description

Serum thyroid function tests (including T3, T4, TSH, Anti-TPO) will be obtained from the singleton pregnancies in the first, second, and third trimester to determine the local specific normal ranges.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
528
Inclusion Criteria
  • Singleton pregnancy
  • Free of pre-existing thyroid disease
  • That do not use thyroid interfering medication
  • That did not undergo IVF treatment
  • TPOAb negative
Exclusion Criteria
  • Adolescent pregnancy
  • Patient with pre-existing thyroid disease
  • TPOAb positive
  • Patient using thyroid interfering medication
  • That had IVF treatment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pregnant womenSerum thyroid function tests500 pregnant women with a singleton pregnancy, free of pre-existing thyroid disease, that do not use thyroid interfering medication, that did not undergo IVF treatment, and are TPOAb negative. Serum thyroid function tests will be obtained on the first visit.
Primary Outcome Measures
NameTimeMethod
TSHOn day 1

Trimester specific TSH level

Secondary Outcome Measures
NameTimeMethod
free T4On day 1

Trimester specific free T4 level

Trial Locations

Locations (1)

Sehit Prof Dr Ilhan Varank Sancaktepe Training and Research Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath